Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
SHG
Shinhan Financial Group Co., Ltd.
Health insurance is a significant component of SHG's insurance offerings.
|
$27.94B |
$53.91
-1.06%
|
|
BIIB
Biogen Inc.
Biogen's LEQEMBI is an Alzheimer's disease therapeutic, a direct product the company manufactures and sells.
|
$26.68B |
$181.50
-0.24%
|
|
STE
STERIS plc
STERIS manufactures surgical equipment, including sterilizers and endoscope-related devices used in operating rooms and infection prevention.
|
$26.28B |
$267.05
+0.07%
|
|
VLTO
Veralto Corporation
Veralto may offer laboratory testing and advisory services around water quality testing and compliance.
|
$25.13B |
$101.77
+0.49%
|
|
BNTX
BioNTech SE
The company is pivoting toward oncology with immunotherapies, making Biotech - Oncology a core product/business focus.
|
$24.62B |
$103.44
+0.73%
|
|
DXCM
DexCom, Inc.
DexCom's core product is continuous glucose monitoring (CGM), i.e., glucose monitoring devices sold as CGM systems.
|
$24.52B |
$63.40
+1.39%
|
|
WAT
Waters Corporation
Waters supplies diagnostic instruments used in laboratories for analytical testing and qualification workflows.
|
$24.23B |
$403.95
-0.78%
|
|
PODD
Insulet Corporation
Insulet's core business is medical devices and equipment, anchored by the Omnipod insulin pump platform.
|
$23.00B |
$325.98
-0.25%
|
|
LH
Labcorp Holdings Inc.
Labcorp offers liquid biopsy tests (e.g., MRD portfolios) as part of its oncology testing portfolio.
|
$22.29B |
$269.12
+0.32%
|
|
JBL
Jabil Inc.
Aseptic filling and dry oral dosage capabilities via Pharmaceutics International (Pii) reflect contract manufacturing services in pharma.
|
$22.24B |
$207.35
+0.06%
|
|
UTHR
United Therapeutics Corporation
UTHR's core PAH/CV therapy portfolio centers on prostacyclin cardiovascular drugs, including Tyvaso, Remodulin, Orenitram, and Ralinepag (where applicable).
|
$22.09B |
$487.27
-0.24%
|
|
DGX
Quest Diagnostics Incorporated
Quest provides laboratory testing services and advisory/regulatory support for microbiology and analytical workflows.
|
$21.21B |
$189.31
-0.20%
|
|
GMAB
Genmab A/S
Genmab is a biotechnology company focused on oncology therapeutics, fitting Biotech - Oncology.
|
$21.12B |
$31.59
-1.02%
|
|
INCY
Incyte Corporation
Incyte's business is centered on oncology-focused therapeutics, including Monjuvi and a broad cancer pipeline.
|
$20.63B |
$104.10
-1.47%
|
|
CHD
Church & Dwight Co., Inc.
Waterpik dental water flossers and related oral-care devices are dental equipment products.
|
$20.60B |
$84.38
-0.20%
|
|
ILMN
Illumina, Inc.
Sequencing instruments and related medical device equipment are Illumina's core manufactured products sold to researchers and clinical labs.
|
$19.95B |
$130.08
+0.21%
|
|
WST
West Pharmaceutical Services, Inc.
West designs and manufactures medical devices and delivery systems (e.g., autoinjectors, prefilled syringes).
|
$19.93B |
$275.12
-0.73%
|
|
CNC
Centene Corporation
Centene's core business is providing health insurance (Medicaid/Medicare and Marketplace) via managed care programs, making Health Insurance its direct product/service.
|
$19.38B |
$39.27
-0.48%
|
|
ZBH
Zimmer Biomet Holdings, Inc.
Zimmer Biomet's core orthopedic devices business centers on joint implants (hips and knees) and related prosthetics.
|
$19.32B |
$97.83
+0.29%
|
|
THC
Tenet Healthcare Corporation
Tenet operates hospitals and hospital-based care delivering inpatient and outpatient services.
|
$19.21B |
$215.80
-0.75%
|
|
EXAS
Exact Sciences Corporation
Oncotype DX is a genomic assay used as a companion diagnostic in oncology, and the company discusses companion diagnostic capabilities and leadership in Precision Oncology.
|
$19.21B |
$101.36
-0.09%
|
|
ULS
UL Solutions Inc.
UL Solutions offers Laboratory Testing & Advisory Services, including regulatory advisory and compliance support.
|
$18.11B |
$90.71
+0.61%
|
|
IFF
International Flavors & Fragrances Inc.
DEB and enzyme-based biotechnologies are core to IFF's Health & Biosciences innovation and product offerings.
|
$17.88B |
$69.89
+0.16%
|
|
SNA
Snap-on Incorporated
RS&I segment includes diagnostic equipment and repair information software platforms.
|
$17.76B |
$341.42
+0.25%
|
|
MEDP
Medpace Holdings, Inc.
Medpace's core business is a specialized full-service CRO delivering Phase I–IV clinical development services.
|
$17.04B |
$593.42
-2.17%
|
|
HOLX
Hologic, Inc.
Panther Panther Fusion molecular diagnostics platform and Aptima/BV/CV/TV assays are diagnostic equipment sold by Hologic.
|
$16.64B |
$74.91
+0.15%
|
|
BWXT
BWX Technologies, Inc.
Radiopharmaceuticals for nuclear medicine imaging and diagnostics.
|
$16.29B |
$178.95
+0.43%
|
|
COO
The Cooper Companies, Inc.
CooperVision and CooperSurgical primarily manufacture ophthalmology devices and related vision-care products, fitting Ophthalmology Devices.
|
$15.55B |
$77.78
-0.20%
|
|
UHS
Universal Health Services, Inc.
UHS has a strong behavioral health care segment offering inpatient and outpatient behavioral health services.
|
$15.54B |
$243.39
-0.32%
|
|
ICLR
ICON Public Limited Company
Directly describes ICON's outsourced drug development and management services as a Contract Research Organization.
|
$15.16B |
$184.84
+0.65%
|
|
NBIX
Neurocrine Biosciences, Inc.
Neurocrine's core focus is neuroscience with programs in neuropsychiatric disorders (MDD, schizophrenia, TD) and related CNS conditions.
|
$15.03B |
$150.88
-0.46%
|
|
SOLV
Solventum Corporation
V.A.C. Peel and Place dressing is a wound care device, a core MedSurg product.
|
$14.78B |
$85.75
+0.56%
|
Showing page 4 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
